Signaling Pathways - Hck - Insulin and Insulin-like Receptors - Arp2/3 complex - Raf
清除全部
- A8716 LY3009120Target: RafSummary: Pan-RAF和RAF二聚体抑制剂
- B1174 LGX818中文名: 康奈非尼Target: RafSummary: RAF抑制剂
- B1407 Dabrafenib (GSK2118436)3 Citation中文名: 达拉菲尼Target: RafSummary: BRAF(V600)突变抑制剂
- B2172 PP121Target: mTOR|Eph Receptors|VEGFR|PDGFR|Bcr-Abl|Src|DNA-PK|P110|HckSummary: 酪氨酸激酶和磷酸肌醇激酶双重抑制剂
- B3058 CK-6361 CitationTarget: Arp2/3 complexSummary: Arp2/3复合体抑制剂
- A8440 GSK1838705ATarget: Insulin and Insulin-like Receptors|ALKSummary: ATP竞争性IGF-IR/IR/ALK抑制剂
- A8313 RAF265Target: Raf|VEGFRSummary: 多细胞激酶抑制剂
- A1302 GSK1904529ATarget: Insulin and Insulin-like ReceptorsSummary: IGF-1R/IR 选择性抑制剂
- A1185 BMS-754807Target: Insulin and Insulin-like ReceptorsSummary: 有效的、选择性的IGF-1R和InsR抑制剂
- A5071 GDC-08791 CitationTarget: RafSummary: B-Raf抑制剂